139 related articles for article (PubMed ID: 3158396)
1. Cyclophosphamide-induced suppressor cells in mice: suppression of the antibody response in vitro and characterization of the effector cells.
Segre M; Tomei E; Segre D
Cell Immunol; 1985 Apr; 91(2):443-54. PubMed ID: 3158396
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide-induced suppressor cells in nude mice.
Shimizu M; Sabolovic D; Ozawa H; Iwaguchi T
Anticancer Drugs; 1992 Aug; 3(4):427-33. PubMed ID: 1421440
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice.
Nikcevich DA; Duffie GP; Young MR; Ellis NK; Kaufman GE; Wepsic HT
Cell Immunol; 1987 Oct; 109(2):349-59. PubMed ID: 2959374
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of splenic natural suppressor cells induced in mice by treatment with cyclophosphamide.
Brooks-Kaiser JC; Bourque LA; Hoskin DW
Immunopharmacology; 1993; 25(2):117-29. PubMed ID: 8500984
[TBL] [Abstract][Full Text] [Related]
5. Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
Gill HK; Liew FY
Eur J Immunol; 1978 Mar; 8(3):172-6. PubMed ID: 306925
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effect of low dose cyclophosphamide treatment on the in vitro antibody response.
Duclos H; Galanaud P; Devinsky O; Maillot MC; Dormont J
Eur J Immunol; 1977 Oct; 7(10):679-84. PubMed ID: 303996
[TBL] [Abstract][Full Text] [Related]
7. A syngeneic splenic cell antigen induces a suppressor T cell in lymph nodes that controls cytotoxic T-cell and primary antibody responses.
Emara M; Battisto JR
Cell Immunol; 1987 Mar; 105(1):205-19. PubMed ID: 2949860
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the humoral response by spleen cells from cyclophosphamide-treated mice.
McIntosh KR; Segre M; Segre D
Immunopharmacology; 1979 Mar; 1(2):165-73. PubMed ID: 162449
[TBL] [Abstract][Full Text] [Related]
9. T-suppressor cells sensitive to cyclophosphamide and to its in vitro active derivative 4-hydroperoxycyclophosphamide control the mitogenic response of murine splenic B cells to dextran sulfate. A direct proof for different sensitivities of lymphocyte subsets to cyclophosphamide.
Diamantstein T; Willinger E; Reiman J
J Exp Med; 1979 Dec; 150(6):1571-6. PubMed ID: 159940
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.
Lagrange PH; Mackaness GB; Miller TE
J Exp Med; 1974 Jun; 139(6):1529-39. PubMed ID: 4598017
[TBL] [Abstract][Full Text] [Related]
11. Anamnestic responses induced by antigen persisting on follicular dendritic cells from cyclophosphamide-treated mice.
Phipps RP; Mandel TE; Schnizlein CT; Tew JG
Immunology; 1984 Feb; 51(2):387-97. PubMed ID: 6607214
[TBL] [Abstract][Full Text] [Related]
12. The influence of cyclophosphamide on antibody formation in the mouse.
Willers JM; Sluis E
Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
[TBL] [Abstract][Full Text] [Related]
13. Studies on induction and control of cell-mediated autoimmunity. II. Prevention of induction and activity of autoreactive T cells by suppressor cells and by a suppressive serum factor.
L'age-Stehr J; Diamantstein T
Eur J Immunol; 1978 Sep; 8(9):624-8. PubMed ID: 309399
[TBL] [Abstract][Full Text] [Related]
14. Non-specific regulatory mechanism of contact sensitivity: the requirement of intermediate cells for non-specific suppressor factor (NSF) activity.
Nakano Y
Immunology; 1988 Jun; 64(2):261-6. PubMed ID: 2968951
[TBL] [Abstract][Full Text] [Related]
15. Differential cyclophosphamide sensitivity of T lymphocytes of the dengue virus-induced suppressor pathway.
Shukla MI; Chaturvedi UC
Br J Exp Pathol; 1984 Aug; 65(4):397-403. PubMed ID: 6235832
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide treatment antagonizes the in vitro development of Mycobacterium lepraemurium-induced suppressor cell precursors.
Gosselin D; Turcotte R; Lemieux S
Clin Exp Immunol; 1992 Aug; 89(2):185-91. PubMed ID: 1386296
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
Ye QW; Mokyr MB
Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cyclophosphamide-induced suppressor cells.
McIntosh KR; Segre M; Segre D
Immunopharmacology; 1982 Aug; 4(4):279-89. PubMed ID: 6181012
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.
Awwad M; North RJ
Cancer Res; 1989 Apr; 49(7):1649-54. PubMed ID: 2522344
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyclophosphamide on spleen cell suppressor activity and tumour growth in mice.
Larsen FS; Spärck JV
Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):323-33. PubMed ID: 6229132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
